What is Xenter?
Founded in 2020 by industry veteran Richard J. Linder, Xenter operates at the nexus of medical technology, data science, and clinical artificial intelligence. The company is fundamentally redefining how healthcare providers interact with patient data by creating a scalable intelligence layer that captures real-time, high-fidelity information during clinical procedures. Unlike traditional medical device manufacturers, Xenter focuses on the creation of a continuous data loop, where every procedure contributes to an expanding library of diagnostic and procedural insights. This approach empowers providers and health systems to move beyond reactive care, facilitating a more proactive, data-informed decision-making process that spans the entire continuum of care. Headquartered in Draper, Utah, the firm is rapidly advancing its mission to integrate intelligent, connected technologies into the standard clinical workflow.
How much funding has Xenter raised?
Xenter has raised a total of $73M across 3 funding rounds:
Seed
$2.8M
Series A
$12M
Series B
$58.3M
Seed (2021): $2.8M, investors not publicly disclosed
Series A (2021): $12M, investors not publicly disclosed
Series B (2026): $58.3M, investors not publicly disclosed
Key Investors in Xenter
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Xenter?
With the successful closure of this latest financing, Xenter is well-positioned to accelerate the deployment of its Physical Intelligence platform across broader clinical environments. The strategic roadmap likely involves scaling the infrastructure required to process massive datasets while simultaneously expanding the reach of its connected medical device portfolio. As the company matures, the focus will shift toward deepening its integration with existing hospital information systems and enhancing the predictive capabilities of its AI models. By leveraging this capital, Xenter aims to solidify its market position as a foundational data layer for the future of digital health, ultimately driving improved patient outcomes through superior clinical intelligence and operational efficiency.
See full Xenter company page
